[{"Assets_0_Q3_USD":"57246000000.0","CIK":"818686","CommonStockSharesConverted_0_Q3_shares":"1198000000.0","Country":"Israel","EarningsPerShareBasic_1_Q3_USD":"-0.29","EarningsPerShareBasic_3_Q3_USD":"-1.02","EarningsPerShareDiluted_1_Q3_USD":"-0.29","EarningsPerShareDiluted_3_Q3_USD":"-1.02","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"11303387401.0","MinorityInterest_0_Q3_USD":"1134000000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":"210000000.0","NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":"-314000000.0","NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":"-1108000000.0","NetIncomeLoss_1_Q3_USD":"-314000000.0","NetIncomeLoss_3_Q3_USD":"-1108000000.0","OfficialName":"Teva Pharmaceutical Industries Limited American Depositary Shares","ProfitLoss_1_Q3_USD":"-307000000.0","ProfitLoss_3_Q3_USD":"-1076000000.0","RevenuesConverted_1_Q3_USD":"4264000000.0","RevenuesConverted_3_Q3_USD":"12896000000.0","SP500":null,"Sector":"Health Care","StockholdersEquityConverted_0_Q3_USD":"14925000000.0","StockholdersEquity_0_Q3_USD":"13790000000.0","Ticker":"TEVA","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":"1092000000.0","WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":"1091000000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":"1092000000.0","WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":"1091000000.0","filed":"20191107","footnote":null,"form":"10-Q","fp":"Q3","fy":"2019.0","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","period":"20190930","qtrs":"0","uom":"USD"}]